Excerpts From Our Interview with Lisa Griffin of Jefferson Health

July 09, 2020

Excerpts from our interview of Lisa Griffin, senior vice president of front-end operation, at Jefferson Health,

FDA Approves Hulio, the Sixth Biosimilar to Humira

July 08, 2020

Along with the other Humira biosimilars, Hulio will not be on the market till 2023.

Lisa Griffin of Jefferson Health Talks Telehealth, COVID-19 (Pt. 1)

July 08, 2020

Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.

Gravie Introduces First-Of-Its-Kind Zero-Copay,-Deductible Employer-Sponsored Health Plan

July 08, 2020

The new plan, called Gravie Comfort, offers 100% coverage on most common healthcare services, including preventive care, primary care, specialist visits, labs and imaging, generic prescriptions, online care, and more – all at a cost comparable to most traditional group health plans.

New USPSTF Lung Cancer Screening Recommendations Would Double Scans Among Blacks, Women

July 08, 2020

Lowering the age and smoking history standards would result in substantially more Blacks and women being eligible for screening.

New Joint Commission Requirements Likely to Boost Maternal Patient Safety

July 07, 2020

The outlook for decreasing the maternal mortality rate in the country has recently improved as a result of a recent initiative by the Joint Commission, which has developed 13 new elements of performance (EOPs) to help evaluate hospitals.

Culture-building is a Business Imperative Amid COVID-19

July 07, 2020

Crisis tests a business's culture. It also is a good time to create or strengthen a culture.

Short 'Bursts' of Oral Corticosteroids Are Associated With GI Bleeds, Other Adverse Events

July 07, 2020

The risk of long-term use of oral corticosteroids are well known. This research shows that short "bursts" of one to two weeks also carry some risk of adverse events.

Stat, Applied XL: COVID-19 Trials Too Small to Give Clear Answers

July 06, 2020

Almost 40% of trials are designed to have fewer than 100 patients.

Boosting Molecular Testing in Patients with GIST Would Have Minimal Cost Impact, Study Finds

July 06, 2020

Researchers cost-impact model calculates the cost to be 15 centers PMPY.

x